PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2020
https://www.valueinhealthjournal.com/article/S1098-3015(18)35322-1/fulltext
Title :
PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35322-1&doi=10.1016/j.jval.2018.09.2020
First page :
Section Title :
Open access? :
No
Section Order :
1373